Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients.
DLBCL is the most common lymphoma subtype occurring in older populations as well as in younger HIV infected patients. The current treatment options for DLBCL are effective for most patients yet the relapse rate is high. While many biomarkers for DLBCL exist, they are not in clinical use due to low sensitivity and specificity. In addition, these biomarkers have not been studied in the HIV context. Therefore, the identification of new biomarkers for HIV negative and HIV positive DLBCL, may lead to a better understanding of the disease pathology and better therapeutic design. Protein biomarkers for DLBCL were determined using MALDI imaging mass spectrometry (IMS) and characterised using LC-MS. The expression of one of the biomarkers, heat shock protein (Hsp) 70, was confirmed on a separate cohort of samples using immunohistochemistry. The biomarkers identified in the study consisted of four protein clusters including glycolytic enzymes, ribosomal proteins, histones and collagen. These proteins could differentiate between control and tumour tissue, and the DLBCL immunohistochemical subtypes in both cohorts. The majority (41/52) of samples in the confirmation cohort were negative for Hsp70 expression. The HIV positive DLBCL cases had a higher percentage of cases expressing Hsp70 than their HIV negative counterparts. The non-GC subtype also frequently overexpressed Hsp70, confirming MALDI IMS data. The expression of Hsp70 did not correlate with survival in both the HIV negative and HIV positive cohort. This study identified potential biomarkers for HIV negative and HIV positive DLBCL from FFPE tissue sections. These may be used as diagnostic and prognostic markers complementary to current clinical management programmes for DLBCL.
Division of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences, University of Cape Town/National Health Laboratory Service, Anzio Road, Observatory, Cape Town, 7925, South Africa.
Pumza
P
Magangane
Division of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences, University of Cape Town/National Health Laboratory Service, Anzio Road, Observatory, Cape Town, 7925, South Africa.
Raveendra
R
Sookhayi
Division of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences, University of Cape Town/National Health Laboratory Service, Anzio Road, Observatory, Cape Town, 7925, South Africa.
Dhirendra
D
Govender
Division of Anatomical Pathology, Department of Pathology, Faculty of Health Sciences, University of Cape Town/National Health Laboratory Service, Anzio Road, Observatory, Cape Town, 7925, South Africa. Richard.Naidoo@uct.ac.za.
Richard
R
Naidoo
D015415:Biomarkers; D003937:Diagnosis, Differential; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism* / Q000401:mortality; D010455:Peptides / Q000378:metabolism; D011379:Prognosis; D020543:Proteome; D040901:Proteomics / Q000379:methods; D019310:Pseudolymphoma / Q000150:complications / Q000175:diagnosis / Q000378:metabolism; D015398:Signal Transduction
D015415:Biomarkers; D010455:Peptides; D020543:Proteome
Biomarker; DLBCL; Heat shock protein; MALDI IMS; Proteome
J Exp Med. 2001 Dec 17;194(12):1861-74
11748286
Semin Cell Dev Biol. 2015 Jul;43:43-51
26277545
Blood. 2004 Jan 1;103(1):275-82
14504078
Nat Rev Immunol. 2002 Dec;2(12):920-32
12461565
Oncogene. 2013 Jun 20;32(25):3101-10
22824801
AIDS. 2015 Apr 24;29(7):811-8
25730510
Mol Cell Proteomics. 2012 May;11(5):77-89
22442255
Cell Stress Chaperones. 2011 Mar;16(2):143-52
20890773
Haematologica. 2010 Aug;95(8):1342-9
20418245
Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):329-39
17993717
J Clin Oncol. 2005 Apr 20;23(12):2797-804
15728226
Nat Rev Immunol. 2013 Aug;13(8):578-91
23883968
J Proteome Res. 2005 Jul-Aug;4(4):1138-42
16083264
BMC Cancer. 2007 Dec 29;7:235
18163913
Ann Hematol. 2014 Aug;93(8):1263-77
24870942
Asian Pac J Cancer Prev. 2013;14(2):929-34
23621263
AIDS. 2014 Mar 13;28(5):689-97
24418826
Biochim Biophys Acta. 1995 Dec 12;1272(3):147-53
8541345
Lancet. 2003 Jul 12;362(9378):139-46
12867117
J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):693-5
16696328
Adv Immunol. 2005;87:163-208
16102574
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
16127175
Cancer Cell Int. 2013 May 24;13(1):48
23706027
Cancer Res. 1993 Mar 15;53(6):1403-8
8095182
World J Gastroenterol. 2014 Apr 14;20(14):3804-24
24744574
Arch Surg. 1991 Apr;126(4):462-6
2009061
Carcinogenesis. 2013 Jun;34(6):1181-8
23563090
J Pathol. 2008 Dec;216(4):387-93
18853439
Mol Cancer Ther. 2009 Apr;8(4):771-8
19372549
Int J Proteomics. 2015;2015:841769
26060582
Anal Chem. 1997 Dec 1;69(23):4751-60
9406525
Blood. 2013 Jul 18;122(3):424-33
23652804
Histopathology. 2001 Dec;39(6):566-71
11903573
Bioanalysis. 2011 Nov;3(21):2427-41
22074284
Semin Cancer Biol. 2013 Dec;23(6):457-67
23999127
Oncogene. 2007 Jan 4;26(1):65-76
16799640
J Bioenerg Biomembr. 2012 Feb;44(1):117-25
22350014
Histochem Cell Biol. 2011 Sep;136(3):227-44
21805154
Exp Cell Res. 2012 Sep 10;318(15):1946-58
22652452
Swiss Med Wkly. 2012 Jan 30;142:w13511
22290632
Cell Death Dis. 2012 Jan 19;3:e255
22258406
Arch Pathol Lab Med. 2008 Jan;132(1):118-24
18181663
Genes Dev. 2005 Mar 1;19(5):570-82
15741319
J Biomed Biotechnol. 2012;2012:156795
23118496
J Mol Histol. 2015 Oct;46(4-5):439-42
26208572
Curr Genomics. 2007 Mar;8(1):43-9
18645623
Cancer Growth Metastasis. 2015 Jul 29;8:35-42
26279629
Clin Biochem. 2013 Apr;46(6):539-45
23388677
Nat Rev Immunol. 2015 Mar;15(3):172-84
25712152
J Pathol. 2015 Jan;235(1):3-13
25201776
BMC Cancer. 2006 Apr 11;6:91
16608517
Virchows Arch. 2013 Oct;463(4):489-95
23913168
Trends Biochem Sci. 2003 Oct;28(10):541-7
14559183
Int J Cancer. 2004 Feb 10;108(4):532-9
14696117
J Clin Oncol. 2009 Oct 20;27(30):5039-48
19752343
Cancer Detect Prev. 1998;22(6):549-55
9824379
BMC Gastroenterol. 2011 Dec 30;11:146
22208848
Cell Mol Life Sci. 2001 Jun;58(7):902-20
11497239
N Engl J Med. 2002 Jun 20;346(25):1937-47
12075054
PLoS One. 2014 May 06;9(5):e96785
24801886
Leukemia. 2015 May;29(5):1163-76
25394713
Mol Cell Biochem. 2007 Jun;300(1-2):19-28
17426931
Biochim Biophys Acta. 2011 Jun;1807(6):755-67
21110941
Expert Rev Proteomics. 2005 Oct;2(5):719-29
16209651
Med Oncol. 2013 Jun;30(2):528
23504336
J Proteome Res. 2010 Apr 5;9(4):1854-63
20170166
J Histochem Cytochem. 2003 May;51(5):567-74
12704204